Page 180
Irish patients are being denied access to nine drugs that are widely available across Europe, largely on cost grounds. A new bulletin published by the Irish Pharmaceutical Healthcare…
A submission paper will be presented to the government later this year outlining steps which need to be taken for Ireland to be at the forefront of its…
Researchers from the School of Physics at NUI Galway have carried out a biological monitoring study among the Irish adult population on non-occupational exposure to glyphosate, an active…
A new network, In4Kids, has been launched to facilitate the development of new drugs for children in Ireland and across Europe. Up to now, paediatric patients generally receive…
Leading consultants have said that many of the difficulties for women with cervical cancer which emerged recently would not have arisen if patients had direct electronic access to…
Minister for Health Simon Harris said there is an urgent need to restore public confidence in the HSE following the cervical cancer tests scandal. With concerns deepening over…
The Taoiseach has apologised to the women who were given incorrect smear test results by the country’s national cervical cancer screening programme. At least 17 of the 208…
Medicines for Ireland, the representative association for generic and biosimilar suppliers in Ireland, has expressed concern that a promised new National Biosimilar Policy will result in no meaningful…
Dublin has missed out in the race to become the new home for the European Medicines Agency post-Brexit. In a nail-biting finale, Amsterdam was chosen as the location…
Prof Michael Barry Clinical Director of the NCPE addressed the PMI on the cost effectiveness of medicines, along with the reimbursement process — a source of much continued debate…
You’re all caught up.
